Executive record

Uri Weinberg

Public governance roles and source-backed Claims for this individual.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:uri-weinbergVersion: public-0As of: 2026-09-28

Not yet claimed5 published Claims1 sources

Key Claims

Biography

Dr. Weinberg has served as Chief Innovation Officer since January 2023 and was additionally appointed Chief Medical Officer in February 2026, leading scientific, pre-clinical, clinical, safety, medical strategy, and biostatistics teams. He joined Novocure in 2008 and most recently held the position of Chief Science Officer from 2020, and holds an M.D. Ph.D. from the Technion Israel Institute of Technology.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Executive career

  1. 2026 to end not publishedExecutive title: Chief Medical Officer and Chief Innovation Officer · Organization not publishedNVCR 10-K executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

1 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. NVCR 10-K executive officers

    sec filing · Source published: Feb 26, 2026 · Retrieved: May 5, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Executive company: Executive at NovoCure Ltd · Claim reviewed: May 5, 2026
    • Executive title: Executive title: Chief Medical Officer and Chief Innovation Officer · Claim reviewed: May 5, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 5, 2026